Loading…

Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids

Background: Omega-3 fatty acids (O3FA) have been used to treat IgA nephropathy (IgAN) but not cutaneous IgA vasculitis (IgAV). Case Report: A 47-year-old female was referred for cutaneous vasculitis. She had a 24-year history of flares of palpable purpura, arthralgia associated with hematuria, and p...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in dermatology 2016-11, Vol.8 (3), p.333-340
Main Authors: Barnadas, Maria A., Díaz Encarnación, Montserrat M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c457t-d944e8f19a7631e6ae7b27021cd67bf43350b5b644ae42b5347406d19674ef753
cites cdi_FETCH-LOGICAL-c457t-d944e8f19a7631e6ae7b27021cd67bf43350b5b644ae42b5347406d19674ef753
container_end_page 340
container_issue 3
container_start_page 333
container_title Case reports in dermatology
container_volume 8
creator Barnadas, Maria A.
Díaz Encarnación, Montserrat M.
description Background: Omega-3 fatty acids (O3FA) have been used to treat IgA nephropathy (IgAN) but not cutaneous IgA vasculitis (IgAV). Case Report: A 47-year-old female was referred for cutaneous vasculitis. She had a 24-year history of flares of palpable purpura, arthralgia associated with hematuria, and proteinuria. We diagnosed cutaneous IgAV associated with IgAN. We administered prednisone at doses ranging from 10 to 45 mg/day to control the flares. To reduce prednisone exposure, different therapeutic strategies (colchicine, diphenhydramine, hydroxyzine, azathioprine, benzathine penicillin, and mycophenolate mofetil) were applied without success. After 11 years, therapy with O3FA capsules containing 460 mg eicosapentaenoic acid and 380 mg of docosahexaenoic acid t.i.d. was introduced, allowing the prednisone to be stopped 2 years later. When the dose of O3FA was decreased to 1 capsule on alternate days, the cutaneous flares reappeared, but they were again controlled when the patient took 1 O3FA capsule daily. Conclusions: O3FA can be useful to control cutaneous IgAV.
doi_str_mv 10.1159/000452320
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_975e0784609b48a6abe756181dba143a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_975e0784609b48a6abe756181dba143a</doaj_id><sourcerecordid>28461812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-d944e8f19a7631e6ae7b27021cd67bf43350b5b644ae42b5347406d19674ef753</originalsourceid><addsrcrecordid>eNptkU1LI0EQhhtx8fvgXWTAk4fZ7e_OXIQQjRsQAot6baqna8bRJBO6O0r-vePOOijsqZqqp56meAk5ZfQnY6r4RSmVigtOd8gB05rnWmmz--W9Tw5jfKZUF0qLPbLPR1KzEeMH5PoPVgHK1IZtNtkkWGG7idmsHmePEMvNoklNzO4DQkKfvTXpKZsvsYZcZFNIaZuNy8bHY_KjgkXEk3_1iDxMb-4nv_O7-e1sMr7LS6lMyn0hJY4qVoDRgqEGNI4bylnptXGVFEJRp5yWElByp4Q0kmrPCm0kVkaJIzLrvb6FZ7sOzRLC1rbQ2L-NNtQWQmrKBdrCKKSmO5MWTo5Ag0OjPm72DpgU0Lmuetd645boS1ylAItv0u-TVfNk6_bVKlEoLmUnuOwFZWhjDFgNu4zaj1jsEEvHnn_9bCA_c-iAsx54gVBjGIBh_-K_48n1TU_Yta_EO4ACmxY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids</title><source>PubMed Central</source><source>Karger Open Access</source><creator>Barnadas, Maria A. ; Díaz Encarnación, Montserrat M.</creator><creatorcontrib>Barnadas, Maria A. ; Díaz Encarnación, Montserrat M.</creatorcontrib><description>Background: Omega-3 fatty acids (O3FA) have been used to treat IgA nephropathy (IgAN) but not cutaneous IgA vasculitis (IgAV). Case Report: A 47-year-old female was referred for cutaneous vasculitis. She had a 24-year history of flares of palpable purpura, arthralgia associated with hematuria, and proteinuria. We diagnosed cutaneous IgAV associated with IgAN. We administered prednisone at doses ranging from 10 to 45 mg/day to control the flares. To reduce prednisone exposure, different therapeutic strategies (colchicine, diphenhydramine, hydroxyzine, azathioprine, benzathine penicillin, and mycophenolate mofetil) were applied without success. After 11 years, therapy with O3FA capsules containing 460 mg eicosapentaenoic acid and 380 mg of docosahexaenoic acid t.i.d. was introduced, allowing the prednisone to be stopped 2 years later. When the dose of O3FA was decreased to 1 capsule on alternate days, the cutaneous flares reappeared, but they were again controlled when the patient took 1 O3FA capsule daily. Conclusions: O3FA can be useful to control cutaneous IgAV.</description><identifier>ISSN: 1662-6567</identifier><identifier>EISSN: 1662-6567</identifier><identifier>DOI: 10.1159/000452320</identifier><identifier>PMID: 28461812</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>IgA vasculitis ; Omega-3 fatty acids ; Single Case</subject><ispartof>Case reports in dermatology, 2016-11, Vol.8 (3), p.333-340</ispartof><rights>2016 The Author(s) Published by S. Karger AG, Basel</rights><rights>Copyright © 2016 The Author(s). Published by S. Karger AG, Basel 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-d944e8f19a7631e6ae7b27021cd67bf43350b5b644ae42b5347406d19674ef753</citedby><cites>FETCH-LOGICAL-c457t-d944e8f19a7631e6ae7b27021cd67bf43350b5b644ae42b5347406d19674ef753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395244/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395244/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27635,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28461812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barnadas, Maria A.</creatorcontrib><creatorcontrib>Díaz Encarnación, Montserrat M.</creatorcontrib><title>Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids</title><title>Case reports in dermatology</title><addtitle>Case Rep Dermatol</addtitle><description>Background: Omega-3 fatty acids (O3FA) have been used to treat IgA nephropathy (IgAN) but not cutaneous IgA vasculitis (IgAV). Case Report: A 47-year-old female was referred for cutaneous vasculitis. She had a 24-year history of flares of palpable purpura, arthralgia associated with hematuria, and proteinuria. We diagnosed cutaneous IgAV associated with IgAN. We administered prednisone at doses ranging from 10 to 45 mg/day to control the flares. To reduce prednisone exposure, different therapeutic strategies (colchicine, diphenhydramine, hydroxyzine, azathioprine, benzathine penicillin, and mycophenolate mofetil) were applied without success. After 11 years, therapy with O3FA capsules containing 460 mg eicosapentaenoic acid and 380 mg of docosahexaenoic acid t.i.d. was introduced, allowing the prednisone to be stopped 2 years later. When the dose of O3FA was decreased to 1 capsule on alternate days, the cutaneous flares reappeared, but they were again controlled when the patient took 1 O3FA capsule daily. Conclusions: O3FA can be useful to control cutaneous IgAV.</description><subject>IgA vasculitis</subject><subject>Omega-3 fatty acids</subject><subject>Single Case</subject><issn>1662-6567</issn><issn>1662-6567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>DOA</sourceid><recordid>eNptkU1LI0EQhhtx8fvgXWTAk4fZ7e_OXIQQjRsQAot6baqna8bRJBO6O0r-vePOOijsqZqqp56meAk5ZfQnY6r4RSmVigtOd8gB05rnWmmz--W9Tw5jfKZUF0qLPbLPR1KzEeMH5PoPVgHK1IZtNtkkWGG7idmsHmePEMvNoklNzO4DQkKfvTXpKZsvsYZcZFNIaZuNy8bHY_KjgkXEk3_1iDxMb-4nv_O7-e1sMr7LS6lMyn0hJY4qVoDRgqEGNI4bylnptXGVFEJRp5yWElByp4Q0kmrPCm0kVkaJIzLrvb6FZ7sOzRLC1rbQ2L-NNtQWQmrKBdrCKKSmO5MWTo5Ag0OjPm72DpgU0Lmuetd645boS1ylAItv0u-TVfNk6_bVKlEoLmUnuOwFZWhjDFgNu4zaj1jsEEvHnn_9bCA_c-iAsx54gVBjGIBh_-K_48n1TU_Yta_EO4ACmxY</recordid><startdate>20161129</startdate><enddate>20161129</enddate><creator>Barnadas, Maria A.</creator><creator>Díaz Encarnación, Montserrat M.</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20161129</creationdate><title>Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids</title><author>Barnadas, Maria A. ; Díaz Encarnación, Montserrat M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-d944e8f19a7631e6ae7b27021cd67bf43350b5b644ae42b5347406d19674ef753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>IgA vasculitis</topic><topic>Omega-3 fatty acids</topic><topic>Single Case</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barnadas, Maria A.</creatorcontrib><creatorcontrib>Díaz Encarnación, Montserrat M.</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Case reports in dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barnadas, Maria A.</au><au>Díaz Encarnación, Montserrat M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids</atitle><jtitle>Case reports in dermatology</jtitle><addtitle>Case Rep Dermatol</addtitle><date>2016-11-29</date><risdate>2016</risdate><volume>8</volume><issue>3</issue><spage>333</spage><epage>340</epage><pages>333-340</pages><issn>1662-6567</issn><eissn>1662-6567</eissn><abstract>Background: Omega-3 fatty acids (O3FA) have been used to treat IgA nephropathy (IgAN) but not cutaneous IgA vasculitis (IgAV). Case Report: A 47-year-old female was referred for cutaneous vasculitis. She had a 24-year history of flares of palpable purpura, arthralgia associated with hematuria, and proteinuria. We diagnosed cutaneous IgAV associated with IgAN. We administered prednisone at doses ranging from 10 to 45 mg/day to control the flares. To reduce prednisone exposure, different therapeutic strategies (colchicine, diphenhydramine, hydroxyzine, azathioprine, benzathine penicillin, and mycophenolate mofetil) were applied without success. After 11 years, therapy with O3FA capsules containing 460 mg eicosapentaenoic acid and 380 mg of docosahexaenoic acid t.i.d. was introduced, allowing the prednisone to be stopped 2 years later. When the dose of O3FA was decreased to 1 capsule on alternate days, the cutaneous flares reappeared, but they were again controlled when the patient took 1 O3FA capsule daily. Conclusions: O3FA can be useful to control cutaneous IgAV.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>28461812</pmid><doi>10.1159/000452320</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1662-6567
ispartof Case reports in dermatology, 2016-11, Vol.8 (3), p.333-340
issn 1662-6567
1662-6567
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_975e0784609b48a6abe756181dba143a
source PubMed Central; Karger Open Access
subjects IgA vasculitis
Omega-3 fatty acids
Single Case
title Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T08%3A44%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Refractory%20Cutaneous%20IgA%20Vasculitis%20Treated%20with%20Omega-3%20Fatty%20Acids&rft.jtitle=Case%20reports%20in%20dermatology&rft.au=Barnadas,%20Maria%C2%A0A.&rft.date=2016-11-29&rft.volume=8&rft.issue=3&rft.spage=333&rft.epage=340&rft.pages=333-340&rft.issn=1662-6567&rft.eissn=1662-6567&rft_id=info:doi/10.1159/000452320&rft_dat=%3Cpubmed_doaj_%3E28461812%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c457t-d944e8f19a7631e6ae7b27021cd67bf43350b5b644ae42b5347406d19674ef753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28461812&rfr_iscdi=true